Ray Dalio’s 10x Genomics TXG Stock Holding History

Ray Dalio’s Portfolio TXG Stock Details TXG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$745K	Sell	35,101 -142,633	-80%	-$2.85M	﹤0.01%	834
2025 Q4	$2.9M	Buy	+177,734	New	+$2.68M	0.01%	681
2023 Q1	–	Sell	-13,044	Closed	-$475K	–	899
2022 Q4	$475K	Buy	+13,044	New	+$426K	﹤0.01%	727
2022 Q3	–	Sell	-8,676	Closed	-$393K	–	1018
2022 Q2	$393K	Buy	8,676 +2,494	+40%	+$129K	﹤0.01%	923
2022 Q1	$470K	Buy	+6,182	New	+$541K	﹤0.01%	896
2021 Q4	–	Sell	-1,988	Closed	-$289K	–	806
2021 Q3	$289K	Buy	+1,988	New	+$341K	﹤0.01%	638

Other funds holding TXG

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

QCM

Quantinno Capital Management New York $59.9B AUM 28.07% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Ray Dalio's TXG Position: Q1 2026 in Review

Ray Dalio reduced its 10x Genomics (TXG) stake by 80% in Q1 2026, selling an estimated $2.85M and leaving 35,101 shares worth $745K. The position accounts for ﹤0.01% of the portfolio, ranked #834.

Ray Dalio first reported a position in TXG in Q3 2021 and has held it in 6 quarters since. The position peaked at $2.9M in Q4 2025. 330 funds tracked by Wall St. Rank hold TXG as of Q1 2026.

Ray Dalio held 35,101 shares of 10x Genomics worth $745K as of Q1 2026.
Ray Dalio sold 142,633 10x Genomics shares in Q1 2026, an estimated $2.85M.
10x Genomics made up ﹤0.01% of Ray Dalio's portfolio in Q1 2026, its #834 holding.
Ray Dalio first reported a position in 10x Genomics in Q3 2021 and has held it in 6 quarters since.
Ray Dalio's 10x Genomics position peaked at $2.9M in Q4 2025.
330 funds tracked by Wall St. Rank held 10x Genomics as of Q1 2026.

Based on Bridgewater Associates's 13F filing for Q1 2026, filed 15 May 2026.